Sagar P. Bapat

University of California, San Francisco, San Francisco, CA 
"Sagar Bapat"
Mean distance: (not calculated yet)


Sign in to add mentor
Suzanne R. Pfeffer research assistant 2005-2009 Stanford
Ronald M. Evans grad student 2009-2017 Salk Institute (Neurotree)
Ye Zheng grad student 2009-2017 Salk Institute (Microtree)
Alexander Marson post-doc 2018- UCSF
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Carnevale J, Shifrut E, Kale N, et al. (2022) RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature
Choi J, Oh TG, Jung H, et al. (2022) Estrogen-Related Receptor γ maintains pancreatic acinar cell function and identity by regulating cellular metabolism. Gastroenterology
Bapat SP, Whitty C, Mowery CT, et al. (2022) Obesity alters pathology and treatment response in inflammatory disease. Nature
Ng DL, Goldgof GM, Shy BR, et al. (2020) SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood. Nature Communications. 11: 4698
Whitman JD, Hiatt J, Mowery CT, et al. (2020) Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nature Biotechnology
Lynch KL, Whitman JD, Lacanienta NP, et al. (2020) Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Whitman JD, Hiatt J, Mowery CT, et al. (2020) Test performance evaluation of SARS-CoV-2 serological assays. Medrxiv : the Preprint Server For Health Sciences
Bapat SP, Liang Y, Zheng Y. (2019) Characterization of Immune Cells from Adipose Tissue. Current Protocols in Immunology. 126: e86
Chang C, Loo CS, Zhao X, et al. (2019) The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America
Nix M, Lin YT, Geng H, et al. (2019) In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell Malignancies Blood. 134: 1337-1337
See more...